Therapy of Schizoaffective Disorder and Paranoid Schizophrenia with Episodic Course

QR Code

Therapy of Schizoaffective Disorder and Paranoid Schizophrenia with Episodic Course

Background. The use of atypical antipsychotics in schizophrenia contributes to the reduction of psychotic, affective, negative and cognitive disorders.Aims. To evaluate the effectiveness of ziprasidone therapy in patients with schizoaffective disorder and paranoid schizophrenia with episodic course....

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	L. A. Ivanova, O. P. Vorsina, T. A. Eliseeva, K. A. Frolovа, E. V. Sapozhnikova
Format:	article
Langue:	RU
Publié:	Scientific Сentre for Family Health and Human Reproduction Problems 2019
Sujets:	schizoaffective disorder schizophrenia ziprasidone Science Q
Accès en ligne:	https://doaj.org/article/70ad0fb5d56344a5be659d884e219320
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder – expert consensus survey part 2
par: Sajatovic M, et autres
Publié: (2018)

Patterns of Thyroid Hormone Prescription in Patients with Bipolar or Schizoaffective Disorder: Findings from the LiSIE Retrospective Cohort Study
par: Ingrid Lieber, et autres
Publié: (2021)

Immunoinflammatory Profile in Patients with Episodic and Continuous Paranoid Schizophrenia
par: Irina K. Malashenkova, et autres
Publié: (2021)

Predictive Utility of Body Mass Index for Metabolic Syndrome Among Patients with Schizophrenia in Japan
par: Sugawara N, et autres
Publié: (2020)

Psychopharmacotherapy of Suicidal Behavior in Schizophrenia and Schizophrenic Spectrum Disorders
par: L. A. Ivanova
Publié: (2020)

Measuring Emotional Awareness in Patients With Schizophrenia and Schizoaffective Disorders
par: Eva Maaßen, et autres
Publié: (2021)

Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics – expert consensus survey part 1
par: Sajatovic M, et autres
Publié: (2018)

Clinical schizophrenia & related psychoses
Publié: (2007)

Metabolic disturbances in patients with paranoid schizophrenia treated with atypical antipsychotic drugs
par: Leonid Mikhaylovich Bardenshteyn, et autres
Publié: (2010)

Reaction Time and Visual Memory in Connection to Hazardous Drinking Polygenic Scores in Schizophrenia, Schizoaffective Disorder and Bipolar Disorder
par: Atiqul Haq Mazumder, et autres
Publié: (2021)

Complete agenesis of the corpus callosum in paranoid schizophrenia—a case report
par: Hari Neupane, et autres
Publié: (2021)

Association of carbohydrate and fatty acid intake with anthropometric parameters in subjects with schizophrenia and bipolar disorders
par: Santillana T,Natalia, et autres
Publié: (2016)

Comparación del efecto de la terapia prolongada con antipsicóticos atípicos o convencionales en la incidencia de diabetes mellitus 2: Revisión sistemática y metaanálisis
par: Sapunar Z,Jorge, et autres
Publié: (2009)

Revisiting the Concepts of Secondary Schizophrenia and Pseudoschizophrenia
par: João Gama Marques
Publié: (2021)

Effect of Switching to Brexpiprazole on Plasma Homovanillic Acid Levels and Antipsychotic-Related Side Effects in Patients with Schizophrenia or Schizoaffective Disorder
par: Ichinose M, et autres
Publié: (2021)

Aberrant Learned Irrelevance in Patients with First-Episode Schizophrenia-Spectrum Disorder
par: Ryan Sai-Ting Chu, et autres
Publié: (2021)

Congruency and phenotypic plasticity of immune and nervous systems in children with autism spectrum disorders compared to schizophrenia spectrum disorders”, Medical Immunology (Russia)
par: A. L. Burmistrova, et autres
Publié: (2020)

Self-stigma in borderline personality disorder – cross-sectional comparison with schizophrenia spectrum disorder, major depressive disorder, and anxiety disorders
par: Grambal A, et autres
Publié: (2016)

Affective theory of the mind and suicide in women with borderline personality disorder and schizophrenia: a comparative study
par: Moustafa Mohamed Mohamed Abdo, et autres
Publié: (2021)

Schizophrenia and sleep disorders: links, risks, and management challenges
par: Kaskie RE, et autres
Publié: (2017)

Identification of Rare Mutations of Two Presynaptic Cytomatrix Genes <i>BSN</i> and <i>PCLO</i> in Schizophrenia and Bipolar Disorder
par: Chia-Hsiang Chen, et autres
Publié: (2021)

Schizophrenia research and treatment

Schizophrenia research
Publié: (1988)

Effective Connectivity between Major Nodes of the Limbic System, Salience and Frontoparietal Networks Differentiates Schizophrenia and Mood Disorders from Healthy Controls
par: Sevdalina Kandilarova, et autres
Publié: (2021)

Treatment of Symptom Clusters in Schizophrenia, Bipolar Disorder and Major Depressive Disorder With the Dopamine D3/D2 Preferring Partial Agonist Cariprazine
par: Borjanka Batinic, et autres
Publié: (2021)

Eye Movements and Cognitive Functioning in Patients With Schizophrenia Spectrum Disorders: Network Analysis
par: Alexander Shmukler, et autres
Publié: (2021)

Pattern of burden on the family of patients with schizophrenia and bipolar disorder: A comparative study
par: Khurshida Khatoon, et autres
Publié: (2021)

Disordered Eating among People with Schizophrenia Spectrum Disorders: A Systematic Review
par: Anoop Sankaranarayanan, et autres
Publié: (2021)

Medication Profile and Treatment Cost Estimation Among Outpatients with Schizophrenia, Bipolar Disorder, Depression, and Anxiety Disorders in Indonesia
par: Puspitasari IM, et autres
Publié: (2020)

Characteristics of auditory hallucinations in Indian patients with schizophrenia and bipolar affective disorder
par: Rajesh S Dhakne, et autres
Publié: (2021)

Clinical Validity of Subjective Clinical Prognosis in First Episode Psychosis Schizophrenia Patients: An Analysis of Data from the European First Episode Schizophrenia Trial (EUFEST) Study
par: Matei VP, et autres
Publié: (2020)

The Evolution of Approaches to Schizophrenia Diagnostics: from Kraepelin to ICD-11
par: Alexander B. Shmukler
Publié: (2021)

First Episode Psychosis and Schizophrenia Are Systemic Neuro-Immune Disorders Triggered by a Biotic Stimulus in Individuals with Reduced Immune Regulation and Neuroprotection
par: Michael Maes, et autres
Publié: (2021)

Combination therapy or monotherapy for the depressed type of schizoaffective disorder
par: Lubomira Iz&aacute;kov&aacute;, et autres
Publié: (2009)

A Short Course Computer-assisted Cognitive Remediation in Patients with Schizophrenia Spectrum Disorders: A Randomized Clinical Trial
par: Samira Hatami, et autres
Publié: (2021)

Duration Mismatch Negativity Predicts Remission in First-Episode Schizophrenia Patients
par: Suguru Nakajima, et autres
Publié: (2021)

Characterization of antipsychotic medications, amino acid signatures, and platelet-activating factor in first-episode psychosis
par: Bracha Erlanger Avigdor, et autres
Publié: (2021)

Changes in Brain Structure, Function, and Network Properties in Patients With First-Episode Schizophrenia Treated With Antipsychotics
par: Ping Yin, et autres
Publié: (2021)

Patients with schizophrenia or schizoaffective disorder who receive multiple electroconvulsive therapy sessions: characteristics, indications, and results
par: Iancu I, et autres
Publié: (2015)

Comparison of self-stigma and quality of life in patients with depressive disorders and schizophrenia spectrum disorders – a cross-sectional study
par: Holubova M, et autres
Publié: (2016)